» Articles » PMID: 22028616

Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma

Overview
Journal Neoplasia
Publisher Elsevier
Specialty Oncology
Date 2011 Oct 27
PMID 22028616
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Although controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopian tube fimbria rather than ovarian surface epithelium. We developed an in vitro model for serous carcinogenesis in which primary human fallopian tube epithelial cells (FTECs) were exposed to potentially oncogenic molecular alterations delivered by retroviral vectors. To more closely mirror in vivo conditions, transformation of FTECs was driven by the positive selection of growth-promoting alterations rather antibiotic selection. Injection of the transformed FTEC lines in SCID mice resulted in xenografts with histologic and immunohistochemical features indistinguishable from poorly differentiated serous carcinomas. Transcriptional profiling revealed high similarity among the transformed and control FTEC lines and patient-derived serous ovarian carcinoma cells and was used to define a malignancy-related transcriptional signature. Oncogene-treated FTEC lines were serially analyzed using quantitative reverse transcription-polymerase chain reaction and immunoblot analysis to identify oncogenes whose expression was subject to positive selection. The combination of p53 and Rb inactivation (mediated by SV40 T antigen), hTERT expression, and oncogenic C-MYC and HRAS accumulation showed positive selection during transformation. Knockdown of each of these selected components resulted in significant growth inhibition of the transformed cell lines that correlated with p27 accumulation. The combination of SV40 T antigen and hTERT expression resulted in immortalized cells that were nontumorigenic in mice, whereas forced expression of a dominant-negative p53 isoform (p53DD) and hTERT resulted in senescence. Thus, our investigation supports the tubal origin of serous carcinoma and provides a dynamic model for studying early molecular alterations in serous carcinogenesis.

Citing Articles

Development of adaptive anoikis resistance promotes metastasis that can be overcome by CDK8/19 Mediator kinase inhibition.

Monavarian M, Page E, Rajkarnikar R, Kumari A, Macias L, Massicano F bioRxiv. 2023; .

PMID: 38106208 PMC: 10723298. DOI: 10.1101/2023.12.04.569970.


3D dynamic cultures of HGSOC organoids to model innovative and standard therapies.

Cavarzerani E, Caligiuri I, Bartoletti M, Canzonieri V, Rizzolio F Front Bioeng Biotechnol. 2023; 11:1135374.

PMID: 37143603 PMC: 10151532. DOI: 10.3389/fbioe.2023.1135374.


PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.

Tabury K, Monavarian M, Listik E, Shelton A, Choi A, Quintens R Life Sci Alliance. 2022; 5(11).

PMID: 35820706 PMC: 9275596. DOI: 10.26508/lsa.202201370.


Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.

Saleh A, Perets R Cancers (Basel). 2021; 13(14).

PMID: 34298679 PMC: 8304959. DOI: 10.3390/cancers13143465.


Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.

Lepage C, Palmer M, Farrell A, Neudorf N, Lichtensztejn Z, Nachtigal M Br J Cancer. 2021; 124(10):1699-1710.

PMID: 33731859 PMC: 8110794. DOI: 10.1038/s41416-021-01317-w.


References
1.
Lawrenson K, Grun B, Benjamin E, Jacobs I, Dafou D, Gayther S . Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia. 2010; 12(4):317-25. PMC: 2847739. DOI: 10.1593/neo.91948. View

2.
Jazaeri A, Yee C, Sotiriou C, Brantley K, Boyd J, Liu E . Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002; 94(13):990-1000. DOI: 10.1093/jnci/94.13.990. View

3.
Crum C, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y . Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007; 5(1):35-44. PMC: 1855333. DOI: 10.3121/cmr.2007.702. View

4.
Ozcan A, Shen S, Hamilton C, Anjana K, Coffey D, Krishnan B . PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011; 24(6):751-64. DOI: 10.1038/modpathol.2011.3. View

5.
Piek J, Verheijen R, Kenemans P, Massuger L, Bulten H, van Diest P . BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol. 2003; 90(2):491. DOI: 10.1016/s0090-8258(03)00365-2. View